Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 9, 2020Current Treatment Options in Cardiovascular MedicineOpen Access

Newer progestin-only contraceptive options have become available and should be considered first-line therapy for women with cardiovascular disease.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Cardiovascular disease is the leading cause of maternal mortality in the USA, requiring providers caring for women with heart disease to have guidance on safe, individualized hormonal and non-hormonal contraceptive options.

Design

Review

Authors

KFKaren FlorioMKMonica KaoTJTraci Johnson

Discussion

Loading...

Member takes

Overview

Emphasizes individualized contraceptive counseling to reduce maternal mortality risk in CVD; leaves open optimal method selection pending prospective data.

Structured PICO

P
Population
Women with cardiovascular disease
I
Intervention
Hormonal and non-hormonal contraceptives (specifically newer progestin-only options)

Provides guidance for cardiologists on prescribing safe and effective contraceptive options, highlighting progestin-only methods as first-line for women with cardiovascular disease.

Cite This Study

Florio et al. (2020) studied this question.

synapsesocial.com/papers/6a73b1d014e943abc869eddahttps://doi.org/10.1007/s11936-020-00853-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Contraceptive Counseling and Options in Patients With Cardiovascular Disease2026
  2. 2Contraception in Women with Cardiac Disease2007 · 7 citations
  3. 3A review of contraceptive methods for women with cardiac disease2018 · 13 citations
  4. 4Kardiyovasküler hastalığı olan kadınlarda kontrasepsiyon ve danışmanlık2023
  5. 5The 2024 US Medical Eligibility Criteria for Contraceptive Use: Application to Practice in the Care of Patients With Cardiac Disease2025 · 5 citations